CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism

J Immunol. 2004 Feb 15;172(4):2286-95. doi: 10.4049/jimmunol.172.4.2286.

Abstract

The magnitude and duration of CD8(+) T cell-mediated responses in the skin to hapten sensitization and challenge, contact hypersensitivity (CHS), is negatively regulated by CD4(+) T cells through an unknown mechanism. In this study we show that CD4(+) T cells restrict the development and expansion of hapten-specific CD8(+) T cells mediating CHS responses to 2,4-dinitrofluorobenzene. In the absence of CD4(+) T cells, high numbers of hapten-specific CD8(+) T cells producing IFN-gamma were detected in the skin-draining lymph nodes on day 5 postsensitization, and these numbers decreased slightly, but were maintained through day 9, correlating with the increased magnitude and duration of CHS responses observed in these mice. In the presence of CD4(+) T cells, the number of hapten-specific CD8(+) T cells producing IFN-gamma detected on day 5 postsensitization was lower and quickly fell to background levels by day 7. The limited development of effector CD8(+) T cells was associated with decreased numbers of hapten-presenting dendritic cells in the lymphoid priming site. This form of immunoregulation was absent after sensitization of Fas ligand-defective gld mice. Transfer of wild-type CD4(+) T cells to gld mice restored the negative regulation of CD8(+) T cell priming and the immune response to hapten challenge in gld-recipient mice. These results indicate that CD4(+) T cells restrict hapten-specific CD8(+) T cell priming for CHS responses through a Fas ligand-dependent mechanism.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Antigen Presentation
  • Apoptosis / genetics
  • Apoptosis / immunology
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / immunology
  • Cell Differentiation / genetics
  • Cell Differentiation / immunology
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology
  • Dermatitis, Contact / genetics
  • Dermatitis, Contact / immunology*
  • Dinitrofluorobenzene / administration & dosage
  • Dinitrofluorobenzene / immunology
  • Dinitrofluorobenzene / metabolism
  • Down-Regulation / genetics
  • Down-Regulation / immunology*
  • Epitopes, T-Lymphocyte / immunology
  • Fas Ligand Protein
  • Female
  • Haptens / administration & dosage
  • Haptens / immunology
  • Haptens / metabolism
  • Ligands
  • Lymph Nodes / immunology
  • Lymph Nodes / metabolism
  • Lymphocyte Count
  • Lymphocyte Depletion
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / deficiency
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • T-Lymphocytes, Regulatory / cytology*
  • T-Lymphocytes, Regulatory / immunology*
  • fas Receptor / metabolism*

Substances

  • Epitopes, T-Lymphocyte
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Haptens
  • Ligands
  • Membrane Glycoproteins
  • fas Receptor
  • Dinitrofluorobenzene